| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthesiology | 15 | 2021 | 157 | 4.780 |
Why?
|
| Critical Care | 16 | 2023 | 370 | 3.980 |
Why?
|
| Anesthesia | 12 | 2022 | 164 | 3.970 |
Why?
|
| Airway Management | 6 | 2024 | 46 | 3.300 |
Why?
|
| Intensive Care Units | 10 | 2023 | 373 | 2.520 |
Why?
|
| Intubation, Intratracheal | 9 | 2024 | 144 | 2.390 |
Why?
|
| Anesthesiologists | 8 | 2023 | 29 | 2.280 |
Why?
|
| Perioperative Care | 6 | 2021 | 161 | 2.040 |
Why?
|
| Anesthetics | 5 | 2023 | 48 | 1.750 |
Why?
|
| Catheterization, Central Venous | 4 | 2020 | 116 | 1.660 |
Why?
|
| Heart Arrest | 5 | 2020 | 265 | 1.510 |
Why?
|
| Cognition | 4 | 2020 | 570 | 1.480 |
Why?
|
| Respiration, Artificial | 8 | 2022 | 334 | 1.450 |
Why?
|
| Humans | 116 | 2024 | 86643 | 1.440 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 301 | 1.380 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2021 | 93 | 1.370 |
Why?
|
| Propofol | 6 | 2008 | 89 | 1.350 |
Why?
|
| Sleep Deprivation | 7 | 2005 | 137 | 1.340 |
Why?
|
| Quality Improvement | 5 | 2021 | 428 | 1.290 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2022 | 139 | 1.200 |
Why?
|
| Pandemics | 3 | 2022 | 740 | 1.180 |
Why?
|
| Checklist | 2 | 2024 | 57 | 1.110 |
Why?
|
| Practice Guidelines as Topic | 5 | 2022 | 1036 | 1.100 |
Why?
|
| Clinical Competence | 4 | 2019 | 751 | 1.070 |
Why?
|
| Operating Rooms | 5 | 2019 | 126 | 1.060 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 316 | 1.040 |
Why?
|
| Burnout, Professional | 2 | 2023 | 94 | 1.010 |
Why?
|
| Societies, Medical | 2 | 2022 | 572 | 0.950 |
Why?
|
| Hypertension, Pregnancy-Induced | 6 | 2021 | 69 | 0.930 |
Why?
|
| Intraoperative Care | 4 | 2022 | 82 | 0.920 |
Why?
|
| Pain Management | 4 | 2018 | 127 | 0.910 |
Why?
|
| Hypnotics and Sedatives | 6 | 2021 | 125 | 0.900 |
Why?
|
| Anesthesia, General | 8 | 2019 | 114 | 0.890 |
Why?
|
| Neuromuscular Blockade | 2 | 2019 | 26 | 0.880 |
Why?
|
| Resuscitation | 1 | 2023 | 100 | 0.880 |
Why?
|
| Positive-Pressure Respiration | 1 | 2022 | 41 | 0.880 |
Why?
|
| Myocardial Infarction | 4 | 2020 | 376 | 0.850 |
Why?
|
| Sleep | 5 | 2005 | 444 | 0.850 |
Why?
|
| Cardiac Surgical Procedures | 4 | 2017 | 462 | 0.830 |
Why?
|
| Analgesia | 1 | 2022 | 57 | 0.830 |
Why?
|
| Fiber Optic Technology | 2 | 2019 | 35 | 0.830 |
Why?
|
| Laryngoscopy | 2 | 2019 | 44 | 0.820 |
Why?
|
| Opioid-Related Disorders | 3 | 2019 | 161 | 0.810 |
Why?
|
| Critical Illness | 3 | 2019 | 294 | 0.780 |
Why?
|
| Aerosols | 1 | 2020 | 44 | 0.770 |
Why?
|
| Monitoring, Intraoperative | 3 | 2018 | 109 | 0.760 |
Why?
|
| Tidal Volume | 4 | 2022 | 53 | 0.750 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2019 | 9 | 0.730 |
Why?
|
| Audiovisual Aids | 1 | 2019 | 7 | 0.730 |
Why?
|
| Physicians | 2 | 2019 | 673 | 0.730 |
Why?
|
| Heart-Assist Devices | 3 | 2023 | 731 | 0.720 |
Why?
|
| Bradycardia | 1 | 2019 | 39 | 0.720 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2019 | 32 | 0.710 |
Why?
|
| Hypertension, Pulmonary | 1 | 2023 | 346 | 0.710 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2020 | 58 | 0.710 |
Why?
|
| Blood Pressure | 5 | 2021 | 1143 | 0.710 |
Why?
|
| Palpation | 1 | 2018 | 18 | 0.680 |
Why?
|
| Pre-Eclampsia | 5 | 2021 | 246 | 0.680 |
Why?
|
| Isoflurane | 3 | 2008 | 64 | 0.670 |
Why?
|
| Health Personnel | 2 | 2021 | 202 | 0.670 |
Why?
|
| Arterial Pressure | 2 | 2018 | 38 | 0.670 |
Why?
|
| Epistaxis | 1 | 2018 | 19 | 0.660 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2018 | 22 | 0.650 |
Why?
|
| Echocardiography | 7 | 2021 | 911 | 0.650 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 746 | 0.650 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2018 | 46 | 0.650 |
Why?
|
| Clinical Decision-Making | 2 | 2019 | 257 | 0.640 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2010 | 148 | 0.630 |
Why?
|
| Blood Loss, Surgical | 2 | 2017 | 112 | 0.630 |
Why?
|
| Prostatectomy | 2 | 2015 | 471 | 0.620 |
Why?
|
| Female | 46 | 2023 | 44532 | 0.620 |
Why?
|
| Blood Pressure Determination | 1 | 2018 | 90 | 0.620 |
Why?
|
| Analgesics, Opioid | 2 | 2018 | 413 | 0.620 |
Why?
|
| Documentation | 1 | 2018 | 98 | 0.620 |
Why?
|
| Drug Overdose | 1 | 2018 | 65 | 0.620 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2019 | 118 | 0.610 |
Why?
|
| Ethics Committees, Research | 1 | 2017 | 33 | 0.610 |
Why?
|
| Mobile Applications | 1 | 2018 | 63 | 0.600 |
Why?
|
| Heart Diseases | 2 | 2021 | 290 | 0.600 |
Why?
|
| Anesthesia, Local | 1 | 2017 | 27 | 0.590 |
Why?
|
| Male | 39 | 2023 | 40965 | 0.590 |
Why?
|
| Research Subjects | 1 | 2017 | 73 | 0.580 |
Why?
|
| Temperature | 1 | 2018 | 396 | 0.580 |
Why?
|
| Ultrasonography | 2 | 2018 | 695 | 0.570 |
Why?
|
| Anesthetics, Local | 1 | 2017 | 76 | 0.560 |
Why?
|
| Vascular Surgical Procedures | 3 | 2012 | 148 | 0.550 |
Why?
|
| Internship and Residency | 2 | 2015 | 1004 | 0.550 |
Why?
|
| Adult | 35 | 2023 | 25648 | 0.540 |
Why?
|
| Patient Readmission | 5 | 2021 | 329 | 0.540 |
Why?
|
| Bronchiolitis | 1 | 2015 | 7 | 0.540 |
Why?
|
| High-Frequency Ventilation | 1 | 2015 | 9 | 0.530 |
Why?
|
| Plasma Substitutes | 1 | 2015 | 9 | 0.530 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 2015 | 6 | 0.530 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2015 | 23 | 0.530 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 102 | 0.530 |
Why?
|
| Laryngeal Edema | 1 | 2015 | 7 | 0.520 |
Why?
|
| Economic Competition | 1 | 2015 | 12 | 0.520 |
Why?
|
| United States | 16 | 2022 | 6672 | 0.520 |
Why?
|
| Ventilators, Mechanical | 3 | 2005 | 33 | 0.520 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2015 | 60 | 0.520 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2015 | 54 | 0.520 |
Why?
|
| Vasopressins | 1 | 2015 | 49 | 0.520 |
Why?
|
| Needs Assessment | 1 | 2016 | 154 | 0.520 |
Why?
|
| Respiratory Sounds | 1 | 2015 | 33 | 0.510 |
Why?
|
| Aldosterone | 1 | 2015 | 65 | 0.510 |
Why?
|
| Acute Kidney Injury | 2 | 2015 | 295 | 0.510 |
Why?
|
| Fluid Therapy | 1 | 2015 | 50 | 0.510 |
Why?
|
| Bronchiolitis, Viral | 1 | 2014 | 4 | 0.510 |
Why?
|
| Oxygen | 4 | 2020 | 726 | 0.500 |
Why?
|
| Intubation | 1 | 2014 | 21 | 0.500 |
Why?
|
| Postpartum Hemorrhage | 1 | 2014 | 24 | 0.500 |
Why?
|
| Albumins | 1 | 2015 | 133 | 0.500 |
Why?
|
| Coronavirus | 1 | 2014 | 19 | 0.490 |
Why?
|
| Malpractice | 1 | 2014 | 57 | 0.480 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 23 | 0.480 |
Why?
|
| Salvage Therapy | 1 | 2015 | 233 | 0.480 |
Why?
|
| Reflex | 2 | 2005 | 79 | 0.480 |
Why?
|
| Medical Errors | 4 | 2018 | 115 | 0.470 |
Why?
|
| Pregnancy | 14 | 2023 | 2894 | 0.470 |
Why?
|
| Blood Glucose | 1 | 2017 | 873 | 0.460 |
Why?
|
| Airway Obstruction | 1 | 2014 | 109 | 0.460 |
Why?
|
| Research Report | 2 | 2020 | 44 | 0.460 |
Why?
|
| Elective Surgical Procedures | 3 | 2021 | 116 | 0.460 |
Why?
|
| Advisory Committees | 2 | 2020 | 90 | 0.450 |
Why?
|
| Retrospective Studies | 21 | 2022 | 8489 | 0.450 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 209 | 0.440 |
Why?
|
| Appointments and Schedules | 2 | 2010 | 53 | 0.430 |
Why?
|
| Electromyography | 2 | 2010 | 183 | 0.430 |
Why?
|
| Insulin | 1 | 2017 | 1160 | 0.430 |
Why?
|
| Postpartum Period | 4 | 2021 | 135 | 0.420 |
Why?
|
| Patient Satisfaction | 3 | 2020 | 455 | 0.420 |
Why?
|
| Middle Aged | 24 | 2023 | 25028 | 0.410 |
Why?
|
| Preoptic Area | 2 | 2001 | 6 | 0.410 |
Why?
|
| Specialties, Surgical | 1 | 2012 | 64 | 0.410 |
Why?
|
| Treatment Outcome | 7 | 2020 | 7993 | 0.410 |
Why?
|
| Ventricular Function, Left | 3 | 2021 | 592 | 0.400 |
Why?
|
| Guideline Adherence | 2 | 2012 | 223 | 0.400 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 112 | 0.400 |
Why?
|
| Activins | 3 | 2021 | 26 | 0.400 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 369 | 0.390 |
Why?
|
| Algorithms | 2 | 2018 | 1830 | 0.390 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2008 | 1219 | 0.390 |
Why?
|
| Cell Proliferation | 2 | 2008 | 1578 | 0.380 |
Why?
|
| Time Factors | 9 | 2022 | 5210 | 0.380 |
Why?
|
| Monitoring, Physiologic | 5 | 2013 | 268 | 0.370 |
Why?
|
| Body Temperature | 2 | 2010 | 124 | 0.370 |
Why?
|
| Databases, Factual | 7 | 2020 | 814 | 0.370 |
Why?
|
| Anesthesia, Conduction | 2 | 2021 | 18 | 0.360 |
Why?
|
| Anesthesia Department, Hospital | 2 | 2019 | 8 | 0.360 |
Why?
|
| Anesthetics, Inhalation | 2 | 2002 | 95 | 0.350 |
Why?
|
| Rats | 11 | 2008 | 3990 | 0.350 |
Why?
|
| Metabolic Syndrome | 1 | 2010 | 141 | 0.340 |
Why?
|
| Forecasting | 1 | 2010 | 304 | 0.340 |
Why?
|
| Neurons | 3 | 2008 | 1546 | 0.340 |
Why?
|
| Psychomotor Agitation | 3 | 2013 | 26 | 0.340 |
Why?
|
| Dentate Gyrus | 2 | 2008 | 32 | 0.340 |
Why?
|
| Kidney | 1 | 2015 | 1241 | 0.340 |
Why?
|
| Prospective Studies | 10 | 2020 | 4213 | 0.330 |
Why?
|
| Decision Making | 2 | 2014 | 642 | 0.330 |
Why?
|
| Ketamine | 1 | 2008 | 24 | 0.320 |
Why?
|
| Dexmedetomidine | 1 | 2008 | 11 | 0.320 |
Why?
|
| Conscious Sedation | 2 | 2006 | 64 | 0.320 |
Why?
|
| Delirium | 3 | 2013 | 66 | 0.320 |
Why?
|
| Inpatients | 3 | 2020 | 297 | 0.300 |
Why?
|
| Mitral Valve Insufficiency | 3 | 2015 | 187 | 0.300 |
Why?
|
| Embolism, Air | 1 | 2007 | 23 | 0.300 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2017 | 104 | 0.290 |
Why?
|
| Respiratory Insufficiency | 2 | 2020 | 150 | 0.290 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2018 | 91 | 0.290 |
Why?
|
| Liver Transplantation | 1 | 2015 | 1268 | 0.290 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2010 | 219 | 0.290 |
Why?
|
| Liver Failure, Acute | 1 | 2006 | 38 | 0.280 |
Why?
|
| Aged | 19 | 2020 | 18415 | 0.280 |
Why?
|
| Hypernatremia | 1 | 2006 | 9 | 0.280 |
Why?
|
| Holoprosencephaly | 1 | 2006 | 11 | 0.280 |
Why?
|
| Risk Factors | 10 | 2021 | 5417 | 0.280 |
Why?
|
| Cleft Palate | 1 | 2006 | 25 | 0.280 |
Why?
|
| Nose | 2 | 2018 | 94 | 0.280 |
Why?
|
| Chordae Tendineae | 2 | 2015 | 23 | 0.270 |
Why?
|
| Adenosine A1 Receptor Antagonists | 1 | 2005 | 4 | 0.270 |
Why?
|
| Electroencephalography | 6 | 2010 | 709 | 0.270 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2005 | 13 | 0.270 |
Why?
|
| Theophylline | 1 | 2005 | 34 | 0.270 |
Why?
|
| Computer Simulation | 2 | 2020 | 1078 | 0.260 |
Why?
|
| Anesthetics, General | 1 | 2005 | 11 | 0.260 |
Why?
|
| Anesthetics, Intravenous | 2 | 2002 | 41 | 0.260 |
Why?
|
| Postoperative Complications | 6 | 2020 | 2207 | 0.260 |
Why?
|
| Sleep, REM | 2 | 2001 | 50 | 0.250 |
Why?
|
| Postnatal Care | 2 | 2021 | 25 | 0.250 |
Why?
|
| Mitral Valve | 3 | 2015 | 248 | 0.250 |
Why?
|
| Hippocampus | 1 | 2008 | 442 | 0.250 |
Why?
|
| Infant | 4 | 2015 | 3046 | 0.250 |
Why?
|
| Blood Transfusion | 2 | 2017 | 157 | 0.250 |
Why?
|
| Heart Ventricles | 2 | 2021 | 760 | 0.250 |
Why?
|
| Anesthesia Recovery Period | 1 | 2004 | 56 | 0.250 |
Why?
|
| Decision Support Techniques | 2 | 2017 | 160 | 0.240 |
Why?
|
| Neoplasms | 1 | 2019 | 2898 | 0.240 |
Why?
|
| Respiratory Mechanics | 1 | 2005 | 102 | 0.240 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 2003 | 6 | 0.240 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 336 | 0.240 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2023 | 60 | 0.230 |
Why?
|
| Wakefulness | 1 | 2024 | 134 | 0.230 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 143 | 0.230 |
Why?
|
| Labetalol | 1 | 2002 | 6 | 0.230 |
Why?
|
| Metoclopramide | 1 | 2002 | 16 | 0.220 |
Why?
|
| Heuristics | 2 | 2019 | 15 | 0.220 |
Why?
|
| Sleep Wake Disorders | 1 | 2004 | 115 | 0.220 |
Why?
|
| Equipment Design | 2 | 2020 | 406 | 0.220 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2020 | 344 | 0.220 |
Why?
|
| Peripartum Period | 2 | 2019 | 20 | 0.220 |
Why?
|
| Cesarean Section | 1 | 2023 | 137 | 0.220 |
Why?
|
| Incidence | 4 | 2024 | 1577 | 0.220 |
Why?
|
| Scleroderma, Systemic | 1 | 2002 | 43 | 0.220 |
Why?
|
| Young Adult | 9 | 2021 | 5976 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2010 | 1961 | 0.210 |
Why?
|
| Biomarkers | 5 | 2021 | 1718 | 0.210 |
Why?
|
| Hemodynamics | 2 | 2018 | 710 | 0.210 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2006 | 3362 | 0.210 |
Why?
|
| Bronchoscopy | 2 | 2024 | 152 | 0.210 |
Why?
|
| Flumazenil | 1 | 2001 | 8 | 0.210 |
Why?
|
| Hiccup | 1 | 2021 | 5 | 0.210 |
Why?
|
| GABA Modulators | 1 | 2001 | 9 | 0.200 |
Why?
|
| Antiemetics | 1 | 2002 | 98 | 0.200 |
Why?
|
| Chicago | 3 | 2021 | 1379 | 0.200 |
Why?
|
| Risk Assessment | 6 | 2020 | 2261 | 0.200 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2001 | 14 | 0.200 |
Why?
|
| Antihypertensive Agents | 2 | 2021 | 521 | 0.200 |
Why?
|
| Nerve Block | 1 | 2021 | 51 | 0.200 |
Why?
|
| Drug Interactions | 1 | 2001 | 248 | 0.190 |
Why?
|
| Pneumonia | 1 | 2002 | 179 | 0.190 |
Why?
|
| Cardiovascular Diseases | 3 | 2021 | 827 | 0.190 |
Why?
|
| One-Lung Ventilation | 1 | 2020 | 4 | 0.190 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 2705 | 0.190 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 1991 | 0.190 |
Why?
|
| Workload | 1 | 2021 | 128 | 0.190 |
Why?
|
| New York City | 1 | 2020 | 59 | 0.190 |
Why?
|
| Washington | 1 | 2020 | 48 | 0.190 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2015 | 516 | 0.190 |
Why?
|
| Nurse Anesthetists | 1 | 2020 | 4 | 0.190 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 30 | 0.190 |
Why?
|
| Personnel, Hospital | 1 | 2020 | 30 | 0.190 |
Why?
|
| Artifacts | 2 | 2018 | 244 | 0.190 |
Why?
|
| Surveys and Questionnaires | 3 | 2023 | 2501 | 0.190 |
Why?
|
| Seasons | 1 | 2021 | 223 | 0.190 |
Why?
|
| Laboratories | 1 | 2020 | 43 | 0.180 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 73 | 0.180 |
Why?
|
| Patient Compliance | 1 | 2021 | 227 | 0.180 |
Why?
|
| Hospital Mortality | 3 | 2020 | 349 | 0.180 |
Why?
|
| Hospitals | 2 | 2021 | 294 | 0.180 |
Why?
|
| Central Venous Catheters | 1 | 2020 | 23 | 0.180 |
Why?
|
| Myocardial Contraction | 1 | 2021 | 244 | 0.180 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 1 | 2020 | 35 | 0.180 |
Why?
|
| Prenatal Care | 1 | 2020 | 72 | 0.180 |
Why?
|
| Health Resources | 1 | 2020 | 76 | 0.180 |
Why?
|
| Ventilation | 1 | 2019 | 7 | 0.180 |
Why?
|
| Narration | 1 | 2019 | 16 | 0.180 |
Why?
|
| Naloxone | 2 | 2018 | 59 | 0.180 |
Why?
|
| Delayed Emergence from Anesthesia | 1 | 2019 | 6 | 0.180 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2015 | 166 | 0.180 |
Why?
|
| Hematoma | 1 | 2020 | 104 | 0.180 |
Why?
|
| Transportation of Patients | 1 | 2019 | 32 | 0.180 |
Why?
|
| Laryngeal Masks | 1 | 2019 | 12 | 0.170 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2019 | 49 | 0.170 |
Why?
|
| Administration, Inhalation | 2 | 2014 | 188 | 0.170 |
Why?
|
| Models, Statistical | 2 | 2018 | 574 | 0.170 |
Why?
|
| Hypertension | 2 | 2018 | 1141 | 0.170 |
Why?
|
| Workflow | 1 | 2019 | 77 | 0.170 |
Why?
|
| Aspirin | 1 | 2020 | 156 | 0.170 |
Why?
|
| Reference Values | 1 | 2020 | 674 | 0.170 |
Why?
|
| Oximetry | 1 | 2019 | 84 | 0.170 |
Why?
|
| Brain | 2 | 2006 | 2216 | 0.170 |
Why?
|
| Laryngoscopes | 1 | 2018 | 9 | 0.170 |
Why?
|
| Obesity | 1 | 2005 | 963 | 0.170 |
Why?
|
| Drug Tolerance | 1 | 2018 | 63 | 0.170 |
Why?
|
| Blood Pressure Monitors | 1 | 2018 | 9 | 0.170 |
Why?
|
| Length of Stay | 2 | 2018 | 702 | 0.160 |
Why?
|
| Aged, 80 and over | 6 | 2019 | 6509 | 0.160 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2020 | 190 | 0.160 |
Why?
|
| Sex Factors | 3 | 2019 | 1054 | 0.160 |
Why?
|
| Calibration | 1 | 2018 | 99 | 0.160 |
Why?
|
| Animals | 14 | 2008 | 26582 | 0.160 |
Why?
|
| Systole | 1 | 2018 | 129 | 0.160 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 306 | 0.160 |
Why?
|
| Ethers | 1 | 1997 | 14 | 0.160 |
Why?
|
| Placenta Growth Factor | 1 | 2018 | 70 | 0.160 |
Why?
|
| Medication Errors | 1 | 2018 | 39 | 0.160 |
Why?
|
| Cyanides | 1 | 1997 | 16 | 0.160 |
Why?
|
| Risk Adjustment | 1 | 2018 | 39 | 0.160 |
Why?
|
| Diastole | 1 | 2018 | 144 | 0.160 |
Why?
|
| Complementary Therapies | 1 | 2018 | 54 | 0.160 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 1621 | 0.160 |
Why?
|
| Nasal Cavity | 1 | 2018 | 91 | 0.160 |
Why?
|
| Comorbidity | 2 | 2018 | 943 | 0.160 |
Why?
|
| Methyl Ethers | 1 | 1997 | 33 | 0.160 |
Why?
|
| Cardiomyopathies | 2 | 2017 | 240 | 0.160 |
Why?
|
| Physician's Role | 1 | 2019 | 179 | 0.150 |
Why?
|
| Hypothermia, Induced | 1 | 2018 | 74 | 0.150 |
Why?
|
| Simulation Training | 1 | 2019 | 88 | 0.150 |
Why?
|
| Case-Control Studies | 5 | 2020 | 1805 | 0.150 |
Why?
|
| Endoglin | 1 | 2017 | 20 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.150 |
Why?
|
| Maternal Mortality | 1 | 2017 | 15 | 0.150 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2018 | 201 | 0.150 |
Why?
|
| Aortic Aneurysm | 1 | 2017 | 80 | 0.150 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2017 | 19 | 0.150 |
Why?
|
| Endoscopy | 1 | 2020 | 332 | 0.150 |
Why?
|
| Narcotic Antagonists | 1 | 2018 | 154 | 0.150 |
Why?
|
| Bromodeoxyuridine | 2 | 2008 | 57 | 0.150 |
Why?
|
| Program Evaluation | 1 | 2018 | 297 | 0.150 |
Why?
|
| Pattern Recognition, Automated | 1 | 2018 | 217 | 0.150 |
Why?
|
| Respiration | 1 | 2018 | 262 | 0.140 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 454 | 0.140 |
Why?
|
| Medicare | 1 | 2020 | 410 | 0.140 |
Why?
|
| Hemorrhage | 1 | 2018 | 268 | 0.140 |
Why?
|
| Angiogenic Proteins | 1 | 2016 | 17 | 0.140 |
Why?
|
| Child | 4 | 2020 | 6927 | 0.140 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 240 | 0.140 |
Why?
|
| Preoperative Care | 2 | 2010 | 397 | 0.140 |
Why?
|
| Surgeons | 1 | 2020 | 238 | 0.140 |
Why?
|
| Shock, Cardiogenic | 1 | 2016 | 95 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 350 | 0.140 |
Why?
|
| Nasal Sprays | 1 | 2015 | 9 | 0.130 |
Why?
|
| Costs and Cost Analysis | 2 | 2015 | 153 | 0.130 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 31 | 0.130 |
Why?
|
| Age Factors | 3 | 2019 | 1851 | 0.130 |
Why?
|
| Robotic Surgical Procedures | 1 | 2020 | 267 | 0.130 |
Why?
|
| Health Facility Size | 1 | 2015 | 9 | 0.130 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 208 | 0.130 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2018 | 318 | 0.130 |
Why?
|
| Catheters | 1 | 2015 | 74 | 0.130 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2015 | 55 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2018 | 319 | 0.130 |
Why?
|
| Helium | 1 | 2014 | 10 | 0.130 |
Why?
|
| Hypoglycemic Agents | 1 | 2017 | 378 | 0.130 |
Why?
|
| Glucose | 1 | 2017 | 638 | 0.130 |
Why?
|
| Cohort Studies | 5 | 2019 | 2767 | 0.120 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 218 | 0.120 |
Why?
|
| Stroke Volume | 1 | 2016 | 456 | 0.120 |
Why?
|
| Mental Processes | 1 | 2014 | 31 | 0.120 |
Why?
|
| Heart | 1 | 2017 | 539 | 0.120 |
Why?
|
| Professional Practice | 1 | 2014 | 46 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 144 | 0.120 |
Why?
|
| Self Concept | 1 | 2014 | 133 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1801 | 0.110 |
Why?
|
| Learning | 1 | 2016 | 280 | 0.110 |
Why?
|
| Sepsis | 1 | 2016 | 306 | 0.110 |
Why?
|
| Antibodies, Viral | 1 | 2014 | 293 | 0.110 |
Why?
|
| Adolescent | 7 | 2019 | 8981 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2014 | 157 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2014 | 217 | 0.110 |
Why?
|
| Bayes Theorem | 1 | 2014 | 361 | 0.110 |
Why?
|
| Pregnancy Outcome | 3 | 2018 | 247 | 0.100 |
Why?
|
| Memory | 1 | 2014 | 225 | 0.100 |
Why?
|
| Ambulatory Care | 2 | 2019 | 181 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2017 | 1538 | 0.100 |
Why?
|
| Sleep Stages | 2 | 2001 | 45 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2015 | 380 | 0.100 |
Why?
|
| Hypocapnia | 1 | 2010 | 6 | 0.100 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2015 | 663 | 0.100 |
Why?
|
| Hematocrit | 1 | 2010 | 68 | 0.090 |
Why?
|
| Hypoxia | 2 | 2014 | 641 | 0.090 |
Why?
|
| Electroconvulsive Therapy | 1 | 2010 | 24 | 0.090 |
Why?
|
| Efficiency | 1 | 2010 | 40 | 0.090 |
Why?
|
| Education | 1 | 2010 | 58 | 0.090 |
Why?
|
| Emotions | 1 | 2014 | 341 | 0.090 |
Why?
|
| Risk Reduction Behavior | 1 | 2010 | 98 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2021 | 3640 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2008 | 3612 | 0.090 |
Why?
|
| Motor Activity | 2 | 2002 | 327 | 0.090 |
Why?
|
| Heart Failure | 1 | 2018 | 1204 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 212 | 0.080 |
Why?
|
| Poverty | 1 | 2010 | 173 | 0.080 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 220 | 0.080 |
Why?
|
| Morbidity | 2 | 2020 | 148 | 0.080 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 158 | 0.080 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2008 | 22 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2010 | 263 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 303 | 0.080 |
Why?
|
| Hospital Costs | 2 | 2019 | 105 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 567 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 1673 | 0.080 |
Why?
|
| Eye Protective Devices | 1 | 2007 | 3 | 0.080 |
Why?
|
| Blindness | 1 | 2007 | 41 | 0.070 |
Why?
|
| Mitral Valve Stenosis | 1 | 2007 | 37 | 0.070 |
Why?
|
| Rupture | 1 | 2007 | 63 | 0.070 |
Why?
|
| Supine Position | 1 | 2006 | 30 | 0.070 |
Why?
|
| Prone Position | 1 | 2007 | 56 | 0.070 |
Why?
|
| Chloral Hydrate | 1 | 2006 | 3 | 0.070 |
Why?
|
| Body Temperature Regulation | 1 | 2006 | 56 | 0.070 |
Why?
|
| Spinal Fusion | 1 | 2007 | 85 | 0.070 |
Why?
|
| Ear, Middle | 1 | 2006 | 24 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2007 | 152 | 0.070 |
Why?
|
| Pulmonary Veins | 1 | 2007 | 72 | 0.070 |
Why?
|
| Sodium Chloride | 1 | 2006 | 88 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2006 | 293 | 0.070 |
Why?
|
| Pain | 2 | 2013 | 391 | 0.070 |
Why?
|
| Receptors, Adenosine A2 | 1 | 2005 | 1 | 0.070 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2005 | 8 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2008 | 303 | 0.070 |
Why?
|
| Air Pressure | 1 | 2005 | 7 | 0.070 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2010 | 582 | 0.060 |
Why?
|
| Triazines | 1 | 2005 | 53 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2005 | 224 | 0.060 |
Why?
|
| Triazoles | 1 | 2005 | 96 | 0.060 |
Why?
|
| Ischemia | 1 | 2006 | 243 | 0.060 |
Why?
|
| Cell Count | 1 | 2005 | 195 | 0.060 |
Why?
|
| Anesthesia, Intravenous | 1 | 2004 | 35 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2003 | 156 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2005 | 596 | 0.060 |
Why?
|
| Intraoperative Period | 1 | 2002 | 90 | 0.050 |
Why?
|
| Postural Balance | 1 | 2002 | 42 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 1982 | 24 | 0.050 |
Why?
|
| Observer Variation | 2 | 2015 | 602 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2005 | 912 | 0.050 |
Why?
|
| Respiratory Function Tests | 1 | 2002 | 136 | 0.050 |
Why?
|
| District of Columbia | 1 | 2021 | 20 | 0.050 |
Why?
|
| Florida | 1 | 2021 | 55 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 429 | 0.050 |
Why?
|
| Texas | 1 | 2021 | 101 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 999 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2001 | 32 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2021 | 80 | 0.050 |
Why?
|
| Phrenic Nerve | 1 | 2021 | 42 | 0.050 |
Why?
|
| Microinjections | 1 | 2001 | 70 | 0.050 |
Why?
|
| Schistosomiasis mansoni | 2 | 1991 | 9 | 0.050 |
Why?
|
| Diaphragm | 1 | 2021 | 50 | 0.050 |
Why?
|
| Job Satisfaction | 1 | 2022 | 73 | 0.050 |
Why?
|
| Evidence-Based Practice | 1 | 2021 | 45 | 0.050 |
Why?
|
| Liver | 1 | 2006 | 1230 | 0.050 |
Why?
|
| Age Distribution | 1 | 2021 | 204 | 0.050 |
Why?
|
| Respiratory System | 1 | 2022 | 116 | 0.050 |
Why?
|
| Spinal Cord | 1 | 1982 | 249 | 0.050 |
Why?
|
| Congresses as Topic | 1 | 2021 | 116 | 0.050 |
Why?
|
| Manikins | 1 | 2020 | 41 | 0.050 |
Why?
|
| Altitude | 1 | 2020 | 40 | 0.050 |
Why?
|
| Follistatin-Related Proteins | 1 | 2020 | 6 | 0.050 |
Why?
|
| Logistic Models | 2 | 2017 | 1186 | 0.050 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 1980 | 48 | 0.050 |
Why?
|
| Follistatin | 1 | 2020 | 7 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2021 | 160 | 0.050 |
Why?
|
| Music | 1 | 2001 | 34 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1753 | 0.050 |
Why?
|
| Awareness | 1 | 2001 | 93 | 0.050 |
Why?
|
| Pressure | 1 | 2020 | 165 | 0.050 |
Why?
|
| Veins | 1 | 2020 | 94 | 0.050 |
Why?
|
| Reaction Time | 1 | 2001 | 309 | 0.050 |
Why?
|
| After-Hours Care | 1 | 2019 | 8 | 0.050 |
Why?
|
| Consensus | 1 | 2021 | 335 | 0.050 |
Why?
|
| Anxiety | 1 | 2022 | 287 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2021 | 170 | 0.040 |
Why?
|
| Evidence-Based Medicine | 2 | 2013 | 429 | 0.040 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2019 | 78 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 2 | 1991 | 272 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 278 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 504 | 0.040 |
Why?
|
| Patient Education as Topic | 1 | 2021 | 351 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 916 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2018 | 70 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1019 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2001 | 373 | 0.040 |
Why?
|
| Polarography | 1 | 1997 | 8 | 0.040 |
Why?
|
| Methemoglobin | 1 | 1997 | 8 | 0.040 |
Why?
|
| Colorimetry | 1 | 1997 | 8 | 0.040 |
Why?
|
| Spectrophotometry | 1 | 1997 | 106 | 0.040 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2017 | 66 | 0.040 |
Why?
|
| Maternal Health Services | 1 | 2017 | 16 | 0.040 |
Why?
|
| Poisoning | 1 | 1997 | 42 | 0.040 |
Why?
|
| Data Collection | 2 | 2010 | 372 | 0.040 |
Why?
|
| Perinatal Care | 1 | 2017 | 18 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2017 | 173 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 364 | 0.040 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2017 | 152 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2018 | 839 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 678 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 376 | 0.030 |
Why?
|
| Models, Biological | 1 | 2002 | 1749 | 0.030 |
Why?
|
| Gestational Age | 1 | 2016 | 311 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1991 | 66 | 0.030 |
Why?
|
| Librarians | 1 | 2013 | 6 | 0.030 |
Why?
|
| Prognosis | 1 | 2021 | 3679 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2013 | 156 | 0.030 |
Why?
|
| Injections, Spinal | 2 | 1982 | 44 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2015 | 563 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2013 | 321 | 0.020 |
Why?
|
| Disease Management | 1 | 2013 | 327 | 0.020 |
Why?
|
| Masks | 1 | 2010 | 29 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2010 | 188 | 0.020 |
Why?
|
| Exercise Test | 1 | 2010 | 164 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 399 | 0.020 |
Why?
|
| Burn Units | 1 | 2008 | 21 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 1988 | 144 | 0.020 |
Why?
|
| Seizures | 1 | 2010 | 297 | 0.020 |
Why?
|
| Interleukins | 1 | 1988 | 134 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 379 | 0.020 |
Why?
|
| Postal Service | 1 | 2007 | 17 | 0.020 |
Why?
|
| Head Protective Devices | 1 | 2007 | 20 | 0.020 |
Why?
|
| Tricuspid Valve | 1 | 2007 | 96 | 0.020 |
Why?
|
| Heart Valve Diseases | 1 | 2007 | 109 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2007 | 148 | 0.020 |
Why?
|
| Interleukin-4 | 3 | 1991 | 127 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1988 | 728 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2008 | 231 | 0.020 |
Why?
|
| Radiography | 1 | 2007 | 813 | 0.020 |
Why?
|
| Heart Rate | 1 | 2007 | 492 | 0.020 |
Why?
|
| Cyclazocine | 1 | 1982 | 1 | 0.010 |
Why?
|
| Phenazocine | 1 | 1982 | 1 | 0.010 |
Why?
|
| Enkephalin, Leucine-2-Alanine | 1 | 1982 | 1 | 0.010 |
Why?
|
| Ethylketocyclazocine | 1 | 1982 | 1 | 0.010 |
Why?
|
| Endorphins | 1 | 1982 | 13 | 0.010 |
Why?
|
| Dynorphins | 1 | 1982 | 14 | 0.010 |
Why?
|
| Enkephalin, Leucine | 1 | 1982 | 6 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1982 | 312 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 1991 | 95 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1981 | 190 | 0.010 |
Why?
|
| Intraoperative Complications | 1 | 1981 | 185 | 0.010 |
Why?
|
| Syndrome | 1 | 1980 | 446 | 0.010 |
Why?
|
| Morphine | 1 | 1980 | 130 | 0.010 |
Why?
|
| Posture | 1 | 1977 | 125 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1991 | 1376 | 0.010 |
Why?
|
| Schistosoma mansoni | 1 | 1991 | 17 | 0.010 |
Why?
|
| CD8 Antigens | 1 | 1991 | 82 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 1991 | 97 | 0.010 |
Why?
|
| Immunization | 1 | 1991 | 158 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 1991 | 177 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 1991 | 152 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1991 | 790 | 0.010 |
Why?
|
| Nematode Infections | 1 | 1988 | 4 | 0.010 |
Why?
|
| Nippostrongylus | 1 | 1988 | 4 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 1988 | 30 | 0.010 |
Why?
|
| Epitopes | 1 | 1988 | 255 | 0.000 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1988 | 158 | 0.000 |
Why?
|
| Immunity, Innate | 1 | 1991 | 409 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1988 | 1047 | 0.000 |
Why?
|
| Mice | 2 | 1991 | 11352 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1991 | 3092 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1988 | 724 | 0.000 |
Why?
|
| Immunosuppressive Agents | 1 | 1988 | 977 | 0.000 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 1977 | 36 | 0.000 |
Why?
|